Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - Integrin - AJM300

AJM300

CAS No. 401905-67-7

AJM300( AJM 300 | AJM-300 )

Catalog No. M14377 CAS No. 401905-67-7

AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 170 Get Quote
10MG 282 Get Quote
25MG 560 Get Quote
50MG 860 Get Quote
100MG 1251 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AJM300
  • Note
    Research use only, not for human use.
  • Brief Description
    AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.
  • Description
    AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.Other Indication Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Mouse model of colitis induced by adoptive transfer of IL-10 deficient CD4+ T cells Dosage:Diet; 0.03, 0.1, 0.3 or 1% Administration:For 15 days Result:Had a histological improvement in epithelial cell hyperplasia, reduced inflammatory cell infiltration and a decrease in mucus production.Prevented an increase in the colon weight in a model of colitis induced by adoptive transfer of CD4+CD45RB high T cells.
  • Synonyms
    AJM 300 | AJM-300
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    401905-67-7
  • Formula Weight
    569.439
  • Molecular Formula
    C28H26Cl2N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (175.61 mM)
  • SMILES
    O=C(OC)[C@H](CC1=CC=C(N2C(N(C)C3=C(C=C(N(C)C)C=C3)C2=O)=O)C=C1)NC(C4=C(Cl)C=CC=C4Cl)=O
  • Chemical Name
    methyl (S)-2-(2,6-dichlorobenzamido)-3-(4-(6-(dimethylamino)-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)phenyl)propanoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Halland N, et al. ACS Med Chem Lett. 2014 Jan 10;5(2):193-8. 2. Park SC, et al. World J Gastroenterol. 2018 May 7;24(17):1868-1880. 3. Sugiura T, et al. J Crohns Colitis. 2013 Dec;7(11):e533-42. 4. Yoshimura N, et al. Gastroenterology. 2015 Dec;149(7):1775-1783.e2.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Echistatin, α1 isofo...

    Potent irreversible αVβ3 integrin antagonist (Ki = 0.27 nM). Disrupts attachment of osteoclasts to bone and inhibits bone reabsorption (IC50 = 0.1 nM). Prevents ADP-induced platelet aggregation via inhibition of glycoprotein IIb/IIIa (GpIIb/IIIa, αIIbβ3) receptors (IC50 = 30 nM) in vitro.

  • LXW7

    LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-peptide (cGRGDdvc) containing unnatural amino acids flanking both sides of the main functional motif.

  • Natalizumab

    Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.

Sign In Join Free